Offer Picking: RBS IBD vs. GS GIR

RBS IBD Full Time vs. GS Research (conditional offer, Start as an PT intern). Both entry level based HK.

Firstly, it is IBD vs. Research. My long term goal is PE or HF.

Secondly, it is Full time vs. Unsecured conditional offer.

Falling into trouble picking up. Any thoughts? Any Strategy I could adopt? How to negociate?

Thanks!!!

19 Comments
 

Correct if I am wrong, but aren't RBS pulling out of Asia? I think I've read somewhere that they are focusing on core markets (EU and US) and are selling something or other in Asia.

GS isn't renowned for its research, but also, RBS isn't renouned for its IBD (bar DCM)

I've seen people going into HFs with Research backgrounds, but at the end of the day it depends on what you want to do: Research or IBD.

__________ Just my 2c.
 
loricanCorrect if I am wrong, but aren't RBS pulling out of Asia? I think I've read somewhere that they are focusing on core markets (EU and US) and are selling something or other in Asia.

GS isn't renowned for its research, but also, RBS isn't renouned for its IBD (bar DCM)

I've seen people going into HFs with Research backgrounds, but at the end of the day it depends on what you want to do: Research or IBD.

Lorican, you are wrong on this.

RBS is NOT pulling out of Asia. RBS is getting rid of its retail banking branches in Asia (which came with the ABN Amro acquisition) and strengthening its Global Markets & Banking division instead. With that said, the M&A team in HK is very good. They advised on some of the biggest deals in the region such as Rio Tinto and etc.

RBS is not known for its IBD, yes. But ABN Amro was a strong M&A adviser in emerging markets and it was especially strong in Eastern and Central Europe, Asia, Middle East and Australia. Despite what you may hear in news and etc., RBS and ABN Amro synergies seem to be working well. I say go for RBS (HK) IBD. You really won't regret it.

-------------------------------------------------- "Whenever I'm about to do something, I think, 'Would an idiot do that?' And if they would, I do NOT do that thing." -Dwight Schrute, "The Office"-
 
BespokeAnalyst2010
loricanCorrect if I am wrong, but aren't RBS pulling out of Asia? I think I've read somewhere that they are focusing on core markets (EU and US) and are selling something or other in Asia.

GS isn't renowned for its research, but also, RBS isn't renouned for its IBD (bar DCM)

I've seen people going into HFs with Research backgrounds, but at the end of the day it depends on what you want to do: Research or IBD.

Lorican, you are wrong on this.

RBS is NOT pulling out of Asia. RBS is getting rid of its retail banking branches in Asia (which came with the ABN Amro acquisition) and strengthening its Global Markets & Banking division instead. With that said, the M&A team in HK is very good. They advised on some of the biggest deals in the region such as Rio Tinto and etc.

RBS is not known for its IBD, yes. But ABN Amro was a strong M&A adviser in emerging markets and it was especially strong in Eastern and Central Europe, Asia, Middle East and Australia. Despite what you may hear in news and etc., RBS and ABN Amro synergies seem to be working well. I say go for RBS (HK) IBD. You really won't regret it.

Good to hear that. And I wasn't attacking RBS btw.

But still, I've had a look at TR and for M&A RBS are 21st for Any Asia (ex-Japan) Involvement Announced, and 21st for completed. They are not in top 10 for Asian debt and neither for Asia ECM.

So other than RBS being a FT offer, I'm not exactly sure what you are basing your recommendation on.

As a side-point, with regards to ABN M&A, after the merger in '07 BarCap poached 40 senior ABM M&A bankers to run it's own division.

__________ Just my 2c.
 

Don't think there is a high chance for FT placement for the GS position - I assume you've noticed that - it's explicitly stated in the ad. Are you sure there's a conditional offer? As far as I am concerned the position is just a PT position, with FT placement possible "subjected to business needs".

So why don't treat that as a pure PT internship and take both - of course you better give HR a heads-up..

Just fyi, RBS IBD certainly has not been doing great - my sources suggested they just had another round of cuts in Nov last year. But it'd still be great for you as a new hire - they are somewhat expanding the analyst class. Deal flow might not be comparable to other BBs but you would def be kept busy. Btw, RBS IBD's not gonna pull out from their Asia core markets (except for their retail/commercial banking businesses), which are and will be their core growth engines..They are also non-existent in the US.

P.S. I'm from one of the HK Unis.

 
LiversamDon't think there is a high chance for FT placement for the GS position - I assume you've noticed that - it's explicitly stated in the ad. Are you sure there's a conditional offer? As far as I am concerned the position is just a PT position, with FT placement possible "subjected to business needs".

So why don't treat that as a pure PT internship and take both - of course you better give HR a heads-up..

Just fyi, RBS IBD certainly has not been doing great - my sources suggested they just had another round of cuts in Nov last year. But it'd still be great for you as a new hire - they are somewhat expanding the analyst class. Deal flow might not be comparable to other BBs but you would def be kept busy. Btw, RBS IBD's not gonna pull out from their Asia core markets (except for their retail/commercial banking businesses), which are and will be their core growth engines..They are also non-existent in the US.

P.S. I'm from one of the HK Unis.

Seems you know quite a lot on GS internship, but must not all the ER full time applicants in HK need to go through a pt first? it's true that "depends on the business needs" but how likely?

For the rbs pull out, i'm afraid you're bit of upside down since rbs is pulling our its commercial/retail banking except others instead... the core of rbs in asia is really abn in fact...

are you doing ib in a BB in hk?

 
fembotmarbs doesn't pay bonuses i hear but then again ER bonus not so high either

RBS (USA) paid $40K (mid bucket) to its analysts.

RBS (UK) paid 20-40K pounds to its analysts.

I know this for sure. Stop giving away misinformation.

-------------------------------------------------- "Whenever I'm about to do something, I think, 'Would an idiot do that?' And if they would, I do NOT do that thing." -Dwight Schrute, "The Office"-
 
Best Response

GS obviously has a great name, but when it comes to research, I've gotten the impression they're not quite as strong as in other areas, on a relative basis Little-known Oppenheimer research, for example, is extremely strong in the energy sector (Fadel Gheit) and Barclays has a lot of strengths in fixed income.

Figure out if you like putting together deals or if you like poring over 10Ks and Qs to try and find hidden land-mines or upside. Personally, I would have more fun poring over 10Ks and other financial statements, but I'm a bit of a geek. One other advantage of research (at most banks) is that you work a few less hours than the IBD guys. That said, I'm guessing the workload between GS Research and RBS IBD will be about even- I had a roommate in GS Capital Markets who worked longer hours than one of my friends in IBD at Merrill.

 

I know a guy who did GS research for 2 years and was able to work afterwards at two very large/prestigious HFs in the US - the jump is possible. But he was based in NY.

Tough choice in my opinion.

 

I'd rather try my luck with GS first. GS research aint that bad: they were the ones who coined the word brics and honestly, GS is good in almost evthg

"What we can, we must; and because we can, we must"
 

Dignissimos aperiam fugit fugit qui ipsa nisi. Vero labore quia occaecati ad numquam animi sed. Odit repudiandae ex asperiores nesciunt odio saepe. Et voluptas voluptate eius aut aut omnis. Natus rerum modi saepe earum.

Quae aut qui nesciunt numquam accusamus temporibus. Perferendis officiis veniam debitis assumenda voluptatem. Est est similique rerum earum ea sint et. Repellat sit quisquam saepe voluptatem et.

Non quia quo neque ullam excepturi. Et amet ipsam voluptas nihil cupiditate sed rerum consequatur. Ad quis rerum itaque beatae ab fuga itaque.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • BMO Capital Markets 11 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”